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Introduction:  Carnitine plays a fundamental role in regulating the balance between fatty acid and carbohydrate metabolism and buffers the acetyl 
CoA pool by rapid conversion into acetyl carnitine via carnitine acetyl transferase (CAT) [1].  Directly monitoring acetyl carnitine kinetics is thus 
instrumental towards unraveling its metabolic pathways and could potentially be a valuable tool for differentiating between healthy and pathological 
metabolism. Recently, it has been demonstrated that the conversion of acetate into acetyl carnitine can be probed in vivo following the infusion of 
hyperpolarized 1-13C acetate [2]. The conversion rates related to this transformation are directly correlated with the enzymatic activity of CAT. The 
aim of the present study was to characterize the dynamics of 1-13C acetate metabolism in skeletal muscle in vivo and to deduce the associated kinetics 
by applying a simple metabolic model.  
 
Materials and methods: A 300 μL sample containing 4.5 M 1-13C acetate, 33 mM 
TEMPO, dissolved in d6-EtOD/D2O 1:2 mixture was turned into frozen glassy beads 
and subsequently polarized in a custom-designed DNP polarizer for 2.5 h [3, 4]. The 
sample was then rapidly dissolved and transferred to a separator/infusion pump within 3 
s, allowing automatic infusing of 2.2 mL 0.2 M  hyperpolarized acetate solution into the 
femoral vein within 9 s. Wild type male Sprague Dawley rats (300 g) were anesthetized 
with 1.5% isoflurane and their physiology was monitored during the experiment. 
Measurements were carried out on a 9.4T/31 cm actively shielded animal scanner 
(Varian/Magnex). Localization was achieved by placing a quadrature 1H/13C carbon 
surface coil with a 10 mm diameter on top of the rat leg skeletal muscle. Series of single 
pulse acquisitions were recorded 12 s after dissolution using 30° adiabatic RF pulses 
applied every 3 s with proton decoupling during the acquisition. The data was analyzed 
in Matlab. A single compartment non-steady state metabolic model for one-site 
exchange was used (fig. 2) to fit the hyperpolarized time courses and determine the 
kinetic (k) and decay rate constants of acetate (R1,A) and acetyl carnitine (R1,C). The 
model includes the correction for the effect of 30° pulses on the signal intensities.  
 
Results and discussion: The time evolution of the precursor acetate and its metabolic 
product, acetyl carnitine, was detected in the skeletal muscle in vivo (n=3) (fig. 1). 
Typically, the line width of acetate was 15 – 20 Hz and 10 – 15 Hz for acetyl carnitine.  
The signal-to-noise ratio of acetyl carnitine was ~20 times lower than that of acetate. 
The acetate signal started decaying 3 s after the end of infusion and the acetyl carnitine 
signal increased to reach its maximum value 12 s after infusion. Due to the high 
concentration of acetate following bolus injection, the conversion rate from labeled 
acetate to acetyl carnitine was likely maximal. The model (fig. 2) reflects the role of 
acetyl carnitine as an energy buffer in resting skeletal muscle. The kinetic rate constant k 
reflects CAT activity, acetyl CoA synthetase activity and membrane transport of acetate, 
and is therefore an “apparent” kinetic rate constant. The decay rate constant of acetate 
R1,A does not correspond to its spin-lattice relaxation rate because it is in fact a 
superposition of the inflow of hyperpolarized acetate and the spin-lattice relaxation rate. 
The peak intensities were fitted to the solutions of the modified Bloch equations starting 
at the onset of acetyl carnitine formation (fig 3). The kinetic rate constant was k = 0.09 ± 
0.03 s-1, the characteristic decay rate R1,A = 0.012 ± 0.002 s-1 and R1,C = 0.093 ± 0.006 s-1.  
 
Conclusion: We deduced the apparent relaxation rates for acetate and acetyl carnitine, 
and the kinetic rate constant for the conversion of acetate into acetyl carnitine in healthy 
skeletal muscle in vivo using the metabolic model described herein. The conversion of 
acetate to acetyl carnitine has been shown to reflect disturbed mitochondrial 
bioenergetics in several tissues [2]. Therefore, local instantaneous measurements of the 
conversion rate have the potential to distinguish healthy and pathological tissues and 
offer insight in the kinetics of altered metabolic states. 
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Fig. 1: Example of the time evolution of hyperpolarized
acetate (182.6 ppm) and acetyl carnitine (174.0 ppm) in
skeletal muscle in vivo. Spectra were acquired every 3
seconds following single 30° pulses. 
Fig. 3: Normalized signal amplitudes of the acetate
and acetyl carnitine spectra showed in fig. 1 are
reported as a function of time starting at the onset of
acetyl carnitine formation. The data were fitted with
the model presented in fig. 2 to extract the exchange
and the decay constants. Time point t=0 depicts the
end of infusion.
Fig. 2: Modified Bloch equations for one site
exchange. Acetate (A), acetyl carnitine (C).  
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